Business

AbbVie in up to $5.6B deal with RemeGen for bispecific antibody for solid tumors

Published On : 2026-01-12

AbbVie in up to $5.6B deal with RemeGen for bispecific antibody for solid tumors

#Business

Discover more from Trend Teller

Subscribe to get the latest posts sent to your email.